Technology
Health
Biotechnology

Leap Therapeutics

$1.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.99%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell LPTX and other stocks, options, ETFs, and crypto commission-free!

About

Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Read More Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Employees
25
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
22.42M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
343.90K
High Today
$1.56
Low Today
$1.51
Open Price
$1.53
Volume
69.28K
52 Week High
$9.45
52 Week Low
$1.35

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical

Earnings

-$0.85
-$0.70
-$0.56
-$0.41
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.41 per share
Actual
-$0.47 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.